Iovance Biotherapeutics Signs New Headquarters Lease and Terminates Previous Lease Agreement
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a Delaware-based biotechnology company, has recently announced significant changes in its office locations and lease agreements. On November 15, 2024, the company finalized a sublease agreement with Vaxcyte, Inc. for Suite 100 at 825 Industrial Road, San Carlos, California. This move comes as part of the company’s strategic initiatives to […]
More Stories
Earnings Season Is About to Begin, and I Expect Positive Changes
By Louis Navellier We’re approaching another earnings season, starting in mid-April, when many of our stocks shine the brightest. Some...
These Detransitioners Sued for Medical Malpractice, but Will They Get Their Day in Court
By Darlene McCormick Sanchez Prisha Mosley thought that she would get her day in court when the North Carolina Legislature...
Cyber Crimes Costing Americans Nearly $21 Billion: FBI
By Naveen Athrappully The FBI released its 2025 Internet Crime Report, revealing that Americans were being defrauded to the tune...
Iran’s Revolutionary Guard Warns Oil Will Be Cut Off ‘For Years’
By Jack Phillips Iran’s Islamic Revolutionary Guard Corps warned on April 7 that the paramilitary group would attempt to block...
California Leads Nation in Diesel Price Spike
By Bill Pan Diesel prices are rising across the nation, and California is taking an especially hard hit, as recent...
Trump Endorses Steve Hilton in Heated Race for California Governor
By Jill McLaughlin Republican Steve Hilton captured President Donald Trump’s endorsement on April 5 in his quest to become the...